News, Policy & Media

Jun 22, 2021
The United Kingdom has entered into formal negotiations around its potential accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). Department for International Trade Minister Liz Truss began discussions on the morning of Tuesday 22nd June with Minister for TPP Yasutoshi Nishimura from Japan, who is this year’s chair of the CPTPP. The United Kingdom would strengthen trade connections with this powerful bloc of economies in the Pacific region –...
Read More
Jun 21, 2021
The Government has announced the establishing of a new ministerial council and Office for Science and Technology Strategy. Prime Minister Boris Johnson will be the chair of the new National Science and Technology Council which will provide strategic direction on the use of scientific and technological tools in tackling great societal challenges in future. Chief Scientific Adviser Sir Patrick Vallance has been asked to lead the Office for Science and Technology Strategy, in conjunction with his c...
Read More
Jun 15, 2021
New antibody tests, described as ‘game-changing’, have been developed by researchers that can detect which variant an individual has immunity from. The tests can pick up on which particular COVID variant(s) someone has been exposed to, something similar antibody tests cannot do. The tests have been developed by researchers from the University of Aberdeen, in a collaboration with the biotechnology group Vertebrate Antibodies Ltd and NHS Grampian. It is not yet clear when these tests w...
Read More
Jun 14, 2021
Some services in the NHS have returned to their pre-pandemic levels, including operations, elective care and cancer treatment. New data from the NHS England show that the number of people waiting more than 52 weeks to start treatment, decreased by more than 50,000 in April. Regarding diagnostic services, 1.8 million patients were able to access testing services in the month of April. There was also an increase in the number of operations and elective care carried out, returning to pre-pandemic l...
Read More
Jun 11, 2021
BIVDA has launched the latest in its series of strategic papers, ‘The Digital Revolution’. You can find a copy of the paper attached to this page. BIVDA is publishing this paper to ensure that the digitisation of In vitro Diagnostics (IVD) and the breakthroughs, experiences and collaboration resultant from the coronavirus pandemic are not limited to being a short-term phenomenon. The last year has demonstrated that the IVD industry has the ability and capacity to transform healt...
Read More
Jun 09, 2021
Business Secretary Kwasi Kwarteng has announced his preferred selection for the chair of UK Research and Innovation (UKRI). Sir Andrew Mackenzie will be tasked with driving forward the Government’s ambitious goals for UK research and innovation. Sir Andrew has a background in both science and business areas. His early career was as an academic geochemist, then moved into industry and was the Chief Executive of BHP (a mining company).Sir Andrew is now Company Chair of Shell and was knighted...
Read More
Jun 02, 2021
A clinically-led review of urgent and emergency care standards has been published by NHS England. The new report has been welcomed by health organisations, patients, clinicians and the public. Findings included in the review have led to recommendations on the reduction of hidden waiting times, the lowering of COVID-19 risks in health settings.  The overall objective of the standards review as to recognise what was clinically important to patients. The review was based on a consultation on t...
Read More
May 27, 2021
According to a new market research report from MarketsandMarkets, the infectious disease diagnostics market could be worth $39.8 billion by 2026. Growing awareness for early disease diagnosis, the prevalence of infectious diseases worldwide and onset of COVID-19 are factors supporting the high growth of this particular market. The infectious disease market is segmented into reagents, kits and consumables, instruments, software and services. The reagents, kits, and consumables segment accounted f...
Read More
May 27, 2021
BIVDA helped to formulate the new NICE Diagnostic Pathology Impact Report and we welcome its publication – we look forward to working with NICE and NHS England stakeholders on making even more progress to improve services.Our External Affairs team has produced a briefing on the report, highlighting its recommendations and future action for engaging with stakeholders, including BIVDA.Links to reports cited in the briefing are as follows:Early Detection and Diagnosis of Cancer RoadmapTh...
Read More
May 25, 2021
A new national public health procurement scheme has gone live to speed up access to supplies and build threat resilience. The new microbiology framework will help to grow capacity, push innovation and build resilience within the microbiology supply chain. The framework is open to all public sector, academic and charitable bodies. It will help to ensure labs and other diagnostic and treatment services have easier and faster access to essential supplies. The framework was designed by Public Health...
Read More
Page 1 of 19 FirstPrevious [1]